TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trial
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trial
Authors
Keywords
Palmitate, PRO-C3
Journal
GASTROENTEROLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-07-23
DOI
10.1053/j.gastro.2021.07.025
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical utility of 30% relative decline in MRI-PDFF in predicting fibrosis regression in non-alcoholic fatty liver disease
- (2021) Nobuharu Tamaki et al. GUT
- Multicenter validation of association between decline in MRI‐PDFF and histologic response in nonalcoholic steatohepatitis
- (2020) Rohit Loomba et al. HEPATOLOGY
- Nonalcoholic Steatohepatitis
- (2020) Adam C. Sheka et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation
- (2020) Jamie Bates et al. JOURNAL OF HEPATOLOGY
- Palmitic acid stimulates NLRP3 inflammasome activation through TLR4-NF-κB signal pathway in hepatic stellate cells
- (2020) Zhixia Dong et al. Annals of Translational Medicine
- Magnetic resonance imaging-proton density fat fraction (MRI-PDFF) to predict treatment response on NASH liver biopsy: a secondary analysis of the resmetirom randomized placebo-controlled phase 2 clinical trial
- (2020) Rohit Loomba et al. JOURNAL OF HEPATOLOGY
- FGF21: An Emerging Therapeutic Target for Non-Alcoholic Steatohepatitis and Related Metabolic Diseases
- (2020) Erik J. Tillman et al. Frontiers in Endocrinology
- MRI‐Proton Density Fat Fraction Treatment Response Criteria in Nonalcoholic Steatohepatitis
- (2020) Rohit Loomba HEPATOLOGY
- Lowering ceramides to overcome diabetes
- (2019) Christine M. Kusminski et al. SCIENCE
- First‐in‐class fatty acid synthase inhibitor TVB‐2640 reduces hepatic de novo lipogenesis in males with metabolic abnormalities
- (2019) Majid M. Syed‐Abdul et al. HEPATOLOGY
- Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease
- (2019) Gordon I. Smith et al. JOURNAL OF CLINICAL INVESTIGATION
- Lipotoxicity and the gut-liver axis in NASH pathogenesis
- (2018) Fabio Marra et al. JOURNAL OF HEPATOLOGY
- Mechanisms of NAFLD development and therapeutic strategies
- (2018) Scott L. Friedman et al. NATURE MEDICINE
- Palmitate-induced lipotoxicity is crucial for the pathogenesis of nonalcoholic fatty liver disease in cooperation with gut-derived endotoxin
- (2018) Yuji Ogawa et al. Scientific Reports
- Factors Associated With Histologic Response in Adult Patients With Nonalcoholic Steatohepatitis
- (2018) Rohit Loomba et al. GASTROENTEROLOGY
- GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease
- (2018) Rohit Loomba et al. GASTROENTEROLOGY
- Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib
- (2018) Saumya Jayakumar et al. JOURNAL OF HEPATOLOGY
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
- (2017) Zobair Younossi et al. Nature Reviews Gastroenterology & Hepatology
- MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice
- (2016) Parambir S. Dulai et al. JOURNAL OF HEPATOLOGY
- Docosahexaenoic acid and palmitic acid reciprocally modulate monocyte activation in part through endoplasmic reticulum stress
- (2016) Ryan G. Snodgrass et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Fatty acid synthesis configures the plasma membrane for inflammation in diabetes
- (2016) Xiaochao Wei et al. NATURE
- An FGF21-Adiponectin-Ceramide Axis Controls Energy Expenditure and Insulin Action in Mice
- (2013) William L. Holland et al. Cell Metabolism
- Role of ceramide in diabetes mellitus: evidence and mechanisms
- (2013) Sehamuddin Galadari et al. Lipids in Health and Disease
- Obesity-Dependent Metabolic Signatures Associated with Nonalcoholic Fatty Liver Disease Progression
- (2012) J. Barr et al. JOURNAL OF PROTEOME RESEARCH
- Role of ceramides in nonalcoholic fatty liver disease
- (2012) Mangesh Pagadala et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Diacylglycerol-mediated insulin resistance
- (2010) Derek M Erion et al. NATURE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now